93 related articles for article (PubMed ID: 19760610)
1. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
[TBL] [Abstract][Full Text] [Related]
2. The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status.
Gupta R; Babb JS; Singh B; Chiriboga L; Liebes L; Adams S; Demaria S
Cancer Invest; 2011 Jul; 29(6):419-25. PubMed ID: 21649468
[TBL] [Abstract][Full Text] [Related]
3. Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodes.
Blighe K; Kenny L; Patel N; Guttery DS; Page K; Gronau JH; Golshani C; Stebbing J; Coombes RC; Shaw JA
PLoS One; 2014; 9(12):e115346. PubMed ID: 25546409
[TBL] [Abstract][Full Text] [Related]
4. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.
Brastianos PK; Carter SL; Santagata S; Cahill DP; Taylor-Weiner A; Jones RT; Van Allen EM; Lawrence MS; Horowitz PM; Cibulskis K; Ligon KL; Tabernero J; Seoane J; Martinez-Saez E; Curry WT; Dunn IF; Paek SH; Park SH; McKenna A; Chevalier A; Rosenberg M; Barker FG; Gill CM; Van Hummelen P; Thorner AR; Johnson BE; Hoang MP; Choueiri TK; Signoretti S; Sougnez C; Rabin MS; Lin NU; Winer EP; Stemmer-Rachamimov A; Meyerson M; Garraway L; Gabriel S; Lander ES; Beroukhim R; Batchelor TT; Baselga J; Louis DN; Getz G; Hahn WC
Cancer Discov; 2015 Nov; 5(11):1164-1177. PubMed ID: 26410082
[TBL] [Abstract][Full Text] [Related]
5. The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes.
Martínez-Gregorio H; Rojas-Jiménez E; Mejía-Gómez JC; Díaz-Velásquez C; Quezada-Urban R; Vallejo-Lecuona F; de la Cruz-Montoya A; Porras-Reyes FI; Pérez-Sánchez VM; Maldonado-Martínez HA; Robles-Estrada M; Bargalló-Rocha E; Cabrera-Galeana P; Ramos-Ramírez M; Chirino YI; Alonso Herrera L; Terrazas LI; Frecha C; Oliver J; Perdomo S; Vaca-Paniagua F
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680239
[TBL] [Abstract][Full Text] [Related]
6. Molecular Features in Lymphatic Metastases Reflect the Metastasis Mechanism of Lymph Nodes With Non-Small-Cell Lung Cancers.
Guo N; Chen Y; Jing Z; Liu S; Su J; Li R; Duan X; Chen Z; Chen P; Yin R; Li S; Tang J
Front Bioeng Biotechnol; 2022; 10():909388. PubMed ID: 35923575
[TBL] [Abstract][Full Text] [Related]
7. Recurrent amplification of RTEL1 and ABCA13 and its synergistic effect associated with clinicopathological data of gastric adenocarcinoma.
Araújo TM; Seabra AD; Lima EM; Assumpção PP; Montenegro RC; Demachki S; Burbano RM; Khayat AS
Mol Cytogenet; 2016; 9():52. PubMed ID: 27366209
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation profiles of breast cancer cells may represent clonal variations of multiple organ metastases.
Horimoto Y; Hlaing MT; Saeki H; Denda-Nagai K; Ishii-Schrade K; Fujihira H; Abe M; Noji M; Shichino S; Saito M; Irimura T
Clin Exp Metastasis; 2024 Jan; ():. PubMed ID: 38193930
[TBL] [Abstract][Full Text] [Related]
9. In silico pathway analysis based on chromosomal instability in breast cancer patients.
Kour A; Sambyal V; Guleria K; Singh NR; Uppal MS; Manjari M; Sudan M
BMC Med Genomics; 2020 Nov; 13(1):168. PubMed ID: 33167967
[TBL] [Abstract][Full Text] [Related]
10. Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis.
Kanwar N; Carmine-Simmen K; Nair R; Wang C; Moghadas-Jafari S; Blaser H; Tran-Thanh D; Wang D; Wang P; Wang J; Pasculescu A; Datti A; Mak T; Lewis JD; Done SJ
EBioMedicine; 2020 Feb; 52():102646. PubMed ID: 32062352
[TBL] [Abstract][Full Text] [Related]
11. Genomics applied to the treatment of breast cancer.
Hamdan D; Nguyen TT; Leboeuf C; Meles S; Janin A; Bousquet G
Oncotarget; 2019 Jul; 10(46):4786-4801. PubMed ID: 31413819
[TBL] [Abstract][Full Text] [Related]
12. Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma.
Behring M; Shrestha S; Manne U; Cui X; Gonzalez-Reymundez A; Grueneberg A; Vazquez AI
Oncotarget; 2018 Dec; 9(96):36836-36848. PubMed ID: 30627325
[TBL] [Abstract][Full Text] [Related]
13. Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases.
Rausch V; Krieg A; Camps J; Behrens B; Beier M; Wangsa D; Heselmeyer-Haddad K; Baldus SE; Knoefel WT; Ried T; Stoecklein NH
BMC Res Notes; 2017 Nov; 10(1):560. PubMed ID: 29110683
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes.
Furet E; El Bouchtaoui M; Feugeas JP; Miquel C; Leboeuf C; Beytout C; Bertheau P; Le Rhun E; Bonneterre J; Janin A; Bousquet G
Oncotarget; 2017 Jun; 8(23):37332-37341. PubMed ID: 28445153
[TBL] [Abstract][Full Text] [Related]
15. Relationship between LINC00341 expression and cancer prognosis.
Liao M; Li B; Zhang S; Liu Q; Liao W; Xie W; Zhang Y
Oncotarget; 2017 Feb; 8(9):15283-15293. PubMed ID: 28146429
[TBL] [Abstract][Full Text] [Related]
16. Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential.
Cava C; Bertoli G; Castiglioni I
BMC Syst Biol; 2015 Sep; 9():62. PubMed ID: 26391647
[TBL] [Abstract][Full Text] [Related]
17. Lack of genomic heterogeneity at high-resolution aCGH between primary breast cancers and their paired lymph node metastases.
Vollebergh MA; Klijn C; Schouten PC; Wesseling J; Israeli D; Ylstra B; Wessels LF; Jonkers J; Linn SC
PLoS One; 2014; 9(8):e103177. PubMed ID: 25083859
[TBL] [Abstract][Full Text] [Related]
18. Integrated genomic and epigenomic analysis of breast cancer brain metastasis.
Salhia B; Kiefer J; Ross JT; Metapally R; Martinez RA; Johnson KN; DiPerna DM; Paquette KM; Jung S; Nasser S; Wallstrom G; Tembe W; Baker A; Carpten J; Resau J; Ryken T; Sibenaller Z; Petricoin EF; Liotta LA; Ramanathan RK; Berens ME; Tran NL
PLoS One; 2014; 9(1):e85448. PubMed ID: 24489661
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
Wikman H; Sielaff-Frimpong B; Kropidlowski J; Witzel I; Milde-Langosch K; Sauter G; Westphal M; Lamszus K; Pantel K
PLoS One; 2012; 7(10):e47537. PubMed ID: 23118876
[TBL] [Abstract][Full Text] [Related]
20. Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast.
Liao S; Desouki MM; Gaile DP; Shepherd L; Nowak NJ; Conroy J; Barry WT; Geradts J
Genes Chromosomes Cancer; 2012 Dec; 51(12):1067-78. PubMed ID: 22887771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
